H-1B sponsorship profile: OCIM Pharmaceuticals LLC. Across U.S. Department of Labor LCA disclosures, OCIM Pharmaceuticals LLC filed 7 Labor Condition Applications covering 7 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (7 certified of 7 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on OCIM Pharmaceuticals LLC’s H-1B petitions range from $60,902 at the low end to $120,000 at the high end, with a petition-weighted average of $81,427. That range reflects the mix of occupations the company sponsors, led by Scientist I (1 petitions at $63,086 avg), followed by Quality Control Scientist I and QC Scientist III. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. OCIM Pharmaceuticals LLC is headquartered in Pine Brook, NJ under NAICS code 5417, and places H-1B workers across 1 state, most heavily in NJ. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where OCIM Pharmaceuticals LLC ranks. By H-1B petition volume, OCIM Pharmaceuticals LLC is #21,197 of 119,880 employers nationally and #1,653 of 5,818 employers headquartered in NJ. Both ranks are computed live from the same underlying petition counts, not a separate estimate.